XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Purchase Agreement
Gilead
Common Stock
Common Stock
Purchase Agreement
Gilead
Additional Paid-In Capital
Additional Paid-In Capital
Purchase Agreement
Gilead
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2019 [1] $ 163,842   $ 4   $ 369,100   $ (205,326) $ 64
Balance, shares at Dec. 31, 2019 [1]     44,212,195          
Issuance of common stock upon exercise of stock options 643       643      
Issuance of common stock upon exercise of stock options, shares     59,939          
Vesting of early exercised stock options 220       220      
Vesting of early exercised stock options, shares     77,388          
Stock-based compensation 3,462       3,462      
Other comprehensive income (loss) 224             224
Net loss (27,753)           (27,753)  
Balance at Mar. 31, 2020 140,638   $ 4   373,425   (233,079) 288
Balance, shares at Mar. 31, 2020     44,349,522          
Balance at Dec. 31, 2020 [1] $ 502,304 [2]   $ 6   830,438   (328,184) 44
Balance, shares at Dec. 31, 2020 65,114,685   63,691,901 [1]          
Issuance of common stock and rights to purchase additional shares in accordance with Amended and Restated Gilead Purchase Agreement, net of $55 offering costs   $ 220,296   $ 1   $ 220,295    
Issuance of common stock and rights to purchase additional shares in accordance with Amended and Restated Gilead Purchase Agreement, net of $55 offering costs, Shares       5,650,000        
Issuance of common stock upon exercise of stock options and vesting of restricted stock $ 1,885       1,885      
Issuance of common stock upon exercise of stock options and vesting of restricted stock, shares     200,828          
Vesting of early exercised stock options 183       183      
Vesting of early exercised stock options, shares     54,039          
Stock-based compensation 12,761       12,761      
Other comprehensive income (loss) (46)             (46)
Net loss (72,593)           (72,593)  
Balance at Mar. 31, 2021 $ 664,790   $ 7   $ 1,065,562   $ (400,777) $ (2)
Balance, shares at Mar. 31, 2021 70,965,513   69,596,768          
[1] The balances as of December 31, 2020 and 2019 have been derived from the audited financial statements as of that date.
[2] The Condensed Consolidated Balance Sheet as of December 31, 2020 has been derived from the audited financial statements as of that date.